Wealthfront’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Wealthfront's BSX Position: Q3 2018 in Review
Wealthfront increased its Boston Scientific (BSX) stake by 4.9% in Q3 2018, buying an estimated $54.6K and bringing the position to 33,382 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #204.
Wealthfront first reported a position in BSX in Q1 2014 and has held it in 19 quarters since. 699 funds tracked by Wall St. Rank hold BSX as of Q3 2018.
- Wealthfront held 33,382 shares of Boston Scientific worth $1.28M as of Q3 2018.
- Wealthfront bought 1,564 Boston Scientific shares in Q3 2018, an estimated $54.6K.
- Boston Scientific made up 0.01% of Wealthfront's portfolio in Q3 2018, its #204 holding.
- Wealthfront first reported a position in Boston Scientific in Q1 2014 and has held it in 19 quarters since.
- 699 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2018.
Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.